key: cord-0948849-s8f3xes1
authors: Seif, Sherif; Ayuna, Ahmed; Kumar, Abhishek; Macdonald, John
title: Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID‐19 patient with ST‐elevation myocardial infarction
date: 2020-05-30
journal: Catheter Cardiovasc Interv
DOI: 10.1002/ccd.29050
sha: 96325c138fa9aaf1d0e950e51d1174615ee64747
doc_id: 948849
cord_uid: s8f3xes1

COVID‐19 is a new viral infection that has a significant impact on global health and economy. Because of its rapid spread worldwide, it may influence the prognosis of other medical conditions, such as ST‐segment elevation myocardial infarction (STEMI). We report a case of a 58‐year female patient admitted with an infero‐posterior STEMI on the background of recently positive COVID‐19 swab. Reperfusion was attempted through primary PCI but unfortunately failed to restore coronary blood flow due to massive thrombotic burden despite several attempts of balloon dilatation and aspiration thrombectomy. She sadly died later on because of hemodynamic deterioration. This scenario raises concerns about Neutrophil Extracellular Traps (NETS) which might potentially have propagated inflammation and thrombosis via platelets' aggregation leading to enhanced coagulopathy and massive coronary thrombosis. Therefore, we suggest primary PCI as the first‐choice of revascularization in patients with combined COVID‐19 and STEMI. Additionally, we emphasize on the importance of using the potent new generation P2Y12 inhibitors along with GPIIb/IIIa inhibitors in every STEMI patient with COVID‐19 to achieve favorable conditions for primary PCI as well as favorable outcomes after stent implantation.

On April 30, a 58-year old female patient presented to the hospital with a 1 hr acute onset chest pain on the background of recently positive SARS-CoV-2 nose swab. ECG revealed infero-posterior STEMI and, the patient immediately received loading doses of dual antiplatelet therapy (ticagrelor 180 mg and aspirin 300 mg) and 2.5 mg of subcutaneous fondaparinux. Revascularization was planned through primary PCI, and the patient was immediately transferred to the catheterization lab. Coronary angiography showed a massive thrombus occluding right coronary artery ( Figure 1 ). An intra-arterial weight-adjusted dose of heparin was administrated. Wiring was successfully performed; however, multiple balloon dilatation failed to restore blood flow ( Figure 2 ). Therefore, aspiration thrombectomy was performed thorough aspiration catheter (export catheter), but also failed despite severe attempts. Intravenous bolus dose injection of GP IIb/IIIa inhibitor (eptifibatide) followed by continuous infusion due to heavy thrombotic burden. Finally, a trial of thrombus aspiration was attempted using 6Fr Guideliner but was unfortunately unsuccessful ( Figure 3 ). The decision was made to abandon the procedure and transfer the patient back to the intensive therapeutic unit (ITU) with continuous 48 hr intravenous infusion of eptifibatide as well as activated coagulation time guided therapeutic intravenous heparin followed by repeat coronary angiography. Also, ticagrelor was replaced by prasugrel (with a 60 mg loading dose). In the ITU intravenous fluids were commenced for low blood pressure.

Additionally, patient's ECG showed atrial tachycardia for which amiodarone infusion was started. Left ventricular ejection fraction was estimated at 40%. Blood results illustrated acute kidney injury (eGFR 28 ml/min, urea 32 mmol/L and creatinine 164 mmol/L), elevated C-reactive protein elevation (225 mg/L) and mild leucocytosis Nevertheless, there is no evidence of direct action for COVID-19 on platelet function. NETS were noticed in patients with severe ARDS and COVID-19; it is associated with the worst prognosis. It was observed that high levels of NETS' highly specific markers were in the sera of COVID-19 patients. 4 Both arterial and venous thrombosis will significantly increase as a result of NETS; therefore, we assume that infection with SARS-CoV-2 has exerted a significant role in this massive intracoronary thrombosis and unfavorable outcome. 5 The acute viral infection is associated with a significant rise in the incidence of acute myocardial infarction as a result of the acute inflammatory response and endothelial dysfunction. 6, 7 Besides, with surging numbers of COVID-19 patients worldwide, concomitantly with the high prevalence of coronary artery disease, it is expected to experience a significant rise in the numbers of patients with combined STEMI and COVID-19. 8 

Accordingly, our case raises concerns about the best strategy to deal with COVID-19 patients presented with STEMI. We believe that the main issue is the high tendency of an infected patient to develop the highly thrombotic field and we assume exaggeration of platelet aggregation with COVID-19 leading to enhanced coagulopathy which could be secondary to NETS. Therefore, we suggest that:

(a) Primary PCI is the first choice in STEMI patients over fibrinolytic therapy that we believe will not be able to deal with such massive thrombus. Of note, we recommend further investigations to confirm this proposed high thrombotic tendency in patients combining STEMI and COVID-19 and our report aims to draw attention toward this specific situation that may be frequently seen in our cardiology cath labs.

COVID-19 and the cardiovascular system

Association of Coronavirus Disease 2019 (COVID-19) with myocardial injury and mortality

Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction Care in Hong Kong

Neutropil extracellular traps in COVID-19

Prominent changes in blood coagulation of patients with SARS-CoV-2 infection

Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients

Viral and bacterial infections in patients with acute myocardial infarction

Risk of myocardial infarction and stroke after acute infection or vaccination

We would like to acknowledge our senior radiographers: Anthony Miccoli, Gina Matheson, and Judith Winnard for their assistance in the management of the patient and in gathering angiographic data for our article.

https://orcid.org/0000-0003-3468-7640Ahmed Ayuna https://orcid.org/0000-0002-2059-8447